BIOLAN HEALTH SL

Their core work

BIOLAN HEALTH is a Spanish medical diagnostics SME that develops affordable, disposable point-of-care (POC) testing devices for common health conditions. They specialize in electrochemical biosensors — compact devices capable of delivering clinically useful results outside a laboratory setting. Their H2020 work demonstrates two concrete applications: a low-cost biosensor for diagnosing lactose intolerance (hypolactasia) and a monitoring device for vitamin D deficiency. They operate at the boundary between biotechnology and medical devices, translating biomarker detection science into practical, accessible diagnostic tools.

What they specialise in

How they've shifted over time

With only two projects and no extracted keywords available, the evolution is narrow but traceable. In their first project (LACTOPOC, 2017–2019), they developed an enzyme-specific electrochemical biosensor for a gastrointestinal diagnostic application, doing so by hosting an MSCA fellow — a model that brings cutting-edge academic biosensor science directly into the company. By their second project (OSAvit-D, 2019–2020), they shifted to a different biomarker category entirely — fat-soluble vitamins — suggesting they are consciously broadening their POC platform beyond a single condition. The direction is from deep single-analyte sensing toward a multi-condition POC diagnostics portfolio.

BIOLAN HEALTH appears to be building a family of low-cost, disposable POC devices targeting common but underdiagnosed conditions, suggesting a deliberate platform strategy rather than a single-product approach.

How they like to work

BIOLAN HEALTH has acted as coordinator on both of their H2020 projects, but with zero recorded unique consortium partners — indicating they operate as a compact, self-directed unit rather than through broad multi-partner consortia. Their use of the MSCA Individual Fellowship scheme for LACTOPOC shows a preference for absorbing individual researchers directly into their team rather than building institutional partnerships. Working with them likely means direct engagement with a small, focused group rather than navigating a complex consortium structure.

BIOLAN HEALTH's recorded H2020 network is minimal — zero unique consortium partners across two projects. Their collaborative footprint is essentially limited to the MSCA fellowship model, where individual scientists are embedded within the company rather than institutional partners being linked externally.

What sets them apart

BIOLAN HEALTH fills a specific niche in the Basque Country medtech ecosystem: a small commercial company with the technical infrastructure and regulatory awareness to turn academic biosensor research into manufacturable, low-cost POC devices. Their track record of hosting MSCA fellows means they are a credible industrial partner for academic groups seeking to translate biosensor science toward real clinical products. For consortia, they bring the rare combination of SME agility, hands-on device fabrication, and direct experience bridging research and commercialization in diagnostics.

Highlights from their portfolio

• LACTOPOC
  BIOLAN HEALTH's largest funded project (€158,122), built under an MSCA Individual Fellowship — demonstrating their model of embedding academic biosensor researchers inside a commercial SME to accelerate device translation.
• OSAvit-D
  Their most recent project extends the POC concept to vitamin D monitoring, confirming a deliberate expansion from gastrointestinal to nutritional diagnostics and signaling a broader product strategy.